RxDoctor Payments Data

Desiree Davis

Gerontology · Hamilton, OHNPI 1245840024

Payments from drug & device makers

$1,528in general payments, 2019–2025

Across 88 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$286
  • Bayer$158
  • Novo Nordisk$138
  • Teva Pharmaceuticals USA, Inc.$111
  • AstraZeneca$111
  • Sunovion Pharmaceuticals Inc.$79
  • plus $644 from 19 others

What the payments were for

  • Food & beverage$1,41793%
  • Education$1117%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,528 in reported general payments places this provider in the 80th percentile of 361 gerontology providers in Ohio.

See all gerontology providers in Ohio

Medicare billing

Part B allowed, 2024
$95,922
Medicare patients
259
Services billed
1,158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$98,742
JardianceEmpagliflozin64$39,627
ZenpepLipase/Protease/Amylase23$38,550
TrulicityDulaglutide35$27,564
EliquisApixaban32$16,490
Nurtec OdtRimegepant Sulfate15$15,950
XcopriCenobamate26$15,430
OxycontinOxycodone Hcl30$9,510
JanuviaSitagliptin Phosphate15$8,567
Atorvastatin Calcium178$5,675
BelsomraSuvorexant28$4,497
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen168$3,492
Potassium Chloride62$2,921
Lorazepam267$2,826
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen187$2,532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$24$98,74212 claims
Boehringer IngelheimJardiance$15$39,62764 claims
PfizerEliquis, Nurtec Odt$37$32,44047 claims
Lilly USA, LLCTrulicity$28$27,56435 claims
MerckJanuvia, Belsomra$75$13,06443 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 361 gerontology providers in Ohio.

Other gerontology in Hamilton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →